Imran focuses his research on developing computational methods to go beyond brute empiricism in biology and medicine. He earned a BS in electrical engineering and computer science from UC Berkeley and a PhD in computer science from Stanford University, where his research on large-scale machine learning systems for drug discovery was co-advised by Vijay Pande and Daphne Koller.
Following his PhD, Imran served for over five years in roles of increasing responsibility at Counsyl (now Myriad Women's Health). As VP, Scientific Affairs, he led a research program in both clinical development, analyzing cohorts of hundreds of thousands of individuals to make discoveries in medical and population genetics; and in technology development, designing assays leveraging the ability to customize both chemistry and computation. Subsequently, he was the first chief scientific officer at Freenome, where he built and led an R&D team spanning molecular biology, computational biology, and machine learning to develop non-invasive blood-based screening protocols for early cancer detection.
In his spare time, Imran builds fast computers, drives fast cars, and skis and bikes at a much more reasonable pace than he did in his blithe youth.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.